Arcadia Biosciences, Inc. (RKDA) Institutional Ownership

Ownership Summary

Arcadia Biosciences, Inc. (NASDAQ:RKDA) currently has 13 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).

• The collective stake of institutional investors in Arcadia Biosciences moved to 2.8% in December 2025, a shift down from the 4.7% reported for September 2025.
• Quarterly data indicates a -9.39% shift in institutional share volume, and the annual owner count reflects a decrease of 13.33%.
• A review of institutional activity for Arcadia Biosciences shows 0 of 13 filers increasing their positions, while 6 reduced their stake, and 7 remained unchanged.
• Collectively, institutional investors decreased their stake in Arcadia Biosciences to 39.11K shares as of December 2025, a change that is down by 4.05K shares quarter on quarter and down 39.42K shares year over year.
• The top institutional stake in Arcadia Biosciences as of December 31, 2025 belongs to VANGUARD GROUP INC, which owns 14.04K shares, or 1.02% of the company.
• Leading sellers of Arcadia Biosciences stock in December 2025 included GEODE CAPITAL MANAGEMENT, LLC (2.35K), MORGAN STANLEY (606), UBS Group AG (534), CITIGROUP INC (355), Tower Research Capital LLC (TRC) (211).
• The top 10 institutional holders of Arcadia Biosciences for the quarter ending December 2025 included VANGUARD GROUP INC (14.04K), STATE STREET CORP (12.15K), GEODE CAPITAL MANAGEMENT, LLC (10.65K), Tower Research Capital LLC (TRC) (1.48K), UBS Group AG (565), SBI Securities Co., Ltd. (120), OSAIC HOLDINGS, INC. (75), GROUP ONE TRADING LLC (18), BANK OF AMERICA CORP /DE/ (12), ASSETMARK, INC (5).